Beam Therapeutics

10 clinical trials to watch in the first half of 2025
BioPharma Dive
Thu, 01/2/25 - 11:42 am
clinical trials
Eli Lilly
cardiovascular disease
Arvinas
protein degradation
Vera Therapeutics
IgA nephropathy
Novarts
pelacarsen
Entyvio
IBD
Novo Nordisk
Alzheimer's disease
Beam Therapeutics
sickle cell disease
COMPASS Pathways
psychedelics
Moderna Therapeutics
Verve Therapeutics
high cholesterol
Beam hits hemoglobin goal in first base editing clinical data, reports death tied to conditioning drug
Fierce Biotech
Tue, 11/5/24 - 10:05 am
Beam Therapeutics
clinical trials
sickle cell disease
CRISPR
base editing
10 clinical trials to watch in the first half of 2024
BioPharma Dive
Wed, 01/3/24 - 05:08 pm
clinical trials
Beam Therapeutics
Moderna Therapeutics
Pfizer
Sanofi
Gilead Sciences
JNJ
Amylx
Roche
Alnylam Pharmaceuticals
Vertex Pharmaceuticals
Lilly buys Beam’s option on Verve drug programs
Pharmaforum
Tue, 10/31/23 - 10:06 am
Eli Lilly
gene editing
Beam Therapeutics
Verve Therapeutics
Beam Therapeutics to cut 20% of workforce as part of restructuring plan
Reuters
Thu, 10/19/23 - 10:04 am
Beam Therapeutics
layoffs
sickle cell disease
AATD
Beam Therapeutics starts dosing in phase 1/2 trial of BEAM-201 in relapsed, refractory T-ALL/T-LL
Benzinga
Tue, 09/5/23 - 11:28 am
Beam Therapeutics
clinical trials
CAR-T
BEAM-201
T-ALL
T-LL
Gene Editing Therapeutics Could Hit the Market in 2023
BioSpace
Mon, 04/10/23 - 11:32 am
gene editing
CRISPR Therapeutics
Vertex Pharmaceuticals
Intellia Therapeutics
Editas Medicine
Beam Therapeutics
A stealth biotech startup is quietly advancing a new drugmaking tool from David Liu’s lab
BioPharma Dive
Wed, 04/5/23 - 07:22 pm
startups
biotech
Beam Therapeutics
Prime Medicine
Resonance Medicine
David Liu
Beam jumps back into off-the-shelf CAR-T race after FDA lifts clinical hold
Fierce Biotech
Fri, 12/2/22 - 11:03 am
Beam Therapeutics
FDA
CAR-T
clinical trials
BEAM-201
Beam-linked startup launches with an eye on the next generation of RNA drugs
BioPharma Dive
Wed, 09/7/22 - 10:24 am
Orbital Therapeutics
Beam Therapeutics
RNA
R&D
Beam details reasons for FDA hold on base editing cancer therapy
BioPharma Dive
Thu, 09/1/22 - 10:29 am
Beam Therapeutics
FDA
gene editing
cancer
Beam reveals what tripped up its base-edited, off-the-shelf CAR-T as it tries to clear FDA hold
Endpoints
Tue, 08/30/22 - 11:50 am
Beam Therapeutics
FDA
CAR-T
FDA halts testing of Beam’s base editing cancer therapy
BioPharma Dive
Mon, 08/1/22 - 10:45 am
Beam Therapeutics
clinical trials
FDA
gene editing
CRISPR
Why Pfizer's Deal With Beam Therapeutics Is a Smart Move
Motley Fool
Mon, 01/24/22 - 10:12 am
Pfizer
Beam Therapeutics
gene editing
Pfizer expands into gene editing with Beam research deal
BioPharma Dive
Mon, 01/10/22 - 11:30 am
Pfizer
Beam Therapeutics
MRNA
gene editing
Biotech M&A tracker: After hitting new heights, deals have slowed down. Here are the latest.
BioPharma Dive
Tue, 08/10/21 - 11:12 pm
M&A
Bayer
Sanofi
Amgen
uniQure
MorphoSys
Xeris Pharmaceuticals
Relay Therapeutics
Merck
Beam Therapeutics
Jazz Pharmaceuticals
2 Winners for a Drug Development Future That Looks Nothing Like the Past
Motley Fool
Fri, 06/4/21 - 10:44 am
genomics
Pacific Biosciences
Beam Therapeutics
Gene editing biotech Beam adds to drug delivery stable with $120M GuideTx buy
Fierce Biotech
Tue, 02/23/21 - 10:51 am
Beam Therapeutics
gene editing
drug delivery
Beam, Verve stockpile cash as investors bank on gene editing progress
BioPharma Dive
Tue, 01/19/21 - 09:13 pm
Beam Therapeutics
Verve Therapeutics
gene editing
funding
This Startup Might Finally Cure Sickle Cell Disease—After A Century Of Racist Neglect
Forbes
Fri, 07/10/20 - 10:54 am
Beam Therapeutics
sickle cell disease
racism

Pages